Drop Down Menu by: rsuitor@yahoo.com

Content on this page requires a newer version of Adobe Flash Player.

healthcare products was borne out of national priority, on May 21, 2000 to ensure availability of effective, safe and affordable Liposomal Amphotericin B. On November 13, 2000 it was incorporated as a medical biotechnology company engaged in research, development, manufacturing and marketing of healthcare products. To address to the unmet medical needs, the company is focused on new age formulations particularly controlled release pharmaceuticals employing an array of technologies of novel drug delivery systems (NDDS).
    Health Product Manufacturers is the most nephrosafe formulation of the most potent fungicidal and the only broad-spectrum antifungal drug Amphotericin B. FUNGISOME® i.v. a liposome-mediated delivery of Amphotericin B to target fungal or leishmania cells was launched on 11th May 2003. In a century of efforts on anti-fungal drug development, it has been found the most effective, safe and the most economical drug for the treatment of life-threatening systemic Fungal Infections and Kala-Azar.
Home |   Fungal Infections |  Kala - Azar |  R & D  |  Management |  Press Room |  Milestones |  Career |  Order |  Enquiry |  Contact Us
  © All Rights Reserved  : Lifecare Innovations Private Limited. 

  Website is best viewed at 1024 x 768 pixels.

Powered by : Axis Softech